Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

Skye Wheatley has dropped a major Ozempic bombshell. The reality star took to her Instagram story on Wednesday to answer some ...

Amanda Bynes was seen looking casual and relaxed while running errands in West Hollywood on Tuesday. She wore a look that covered up her figure after admitting she was going on Ozempic ...

Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...

The intense demand for GLP-1 agonists stems from their proven efficacy in managing type 2 diabetes and, increasingly, in facilitating significant weight loss. However, patients often face substantial ...

Biocon aims to introduce generic versions of the obesity drug Wegovy in India and Canada by late 2026 or early 2027, ...

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...

GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity or type 2 diabetes, researchers reported in San Francisco at ENDO 2025, the ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years, a top executive told Reuters ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

The official's remarks come amid growing concern from medical professionals about the increasing popularity of weight-loss ...